These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6862304)

  • 1. Induction of histiocytomas by pristane treatment of mice chronically infected with Moloney murine leukemia virus.
    Nobis P; Löhler J
    Haematol Blood Transfus; 1983; 28():280-1. PubMed ID: 6862304
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of retroviruses during early mouse embryogenesis.
    Jaenisch R; Harbers K; Jähner D; Stewart C; Stuhlmann H
    Haematol Blood Transfus; 1983; 28():270-4. PubMed ID: 6862303
    [No Abstract]   [Full Text] [Related]  

  • 3. Moloney murine leukemia virus-induced myeloid tumors in adult BALB/c mice: requirement of c-myb activation but lack of v-abl involvement.
    Shen-Ong GL; Wolff L
    J Virol; 1987 Dec; 61(12):3721-5. PubMed ID: 2824810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of viral and cellular recombinational events in murine leukemia.
    Fischinger PJ; Dunlop NM; Dekaban GA; Robey WG
    Transplant Proc; 1984 Apr; 16(2):428-34. PubMed ID: 6326352
    [No Abstract]   [Full Text] [Related]  

  • 5. The physiopathology of Friend leukemia.
    Tambourin PE; Wendling F; Jasmin C; Smadja-Joffe F
    Leuk Res; 1979; 3(3):117-29. PubMed ID: 381791
    [No Abstract]   [Full Text] [Related]  

  • 6. The integration sites of endogenous and exogenous Moloney murine leukemia virus.
    van der Putten H; Terwindt E; Berns A; Jaenisch R
    Cell; 1979 Sep; 18(1):109-16. PubMed ID: 509516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased pathogenicity of murine leukemia virus-Moloney in gnotobiotic mice.
    Isaak DD; Bartizal KF; Caulfield MJ
    Leukemia; 1988 Aug; 2(8):540-4. PubMed ID: 3261822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of a murine sarcoma virus.
    Kirsten WH; Schauf V; McCoy J
    Bibl Haematol; 1970; (36):246-9. PubMed ID: 5538357
    [No Abstract]   [Full Text] [Related]  

  • 9. An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo.
    Brightman BK; Rein A; Trepp DJ; Fan H
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2264-8. PubMed ID: 2006167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic masking of nondefective recombinant murine leukemia virus in Moloney virus stocks.
    Fischinger PJ; Blevins CS; Dunlop NM
    Science; 1978 Aug; 201(4354):457-9. PubMed ID: 663667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of M-MSV tumors in mice carrying endogenized Moloney leukemia virus.
    Chieco-Bianchi L; D'Andrea E; De Rossi A; Zanovello P; Ronchese F; Collavo D
    Haematol Blood Transfus; 1983; 28():275-9. PubMed ID: 6602736
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic basis of disease specificity of nondefective Friend murine leukemia virus.
    Hopkins N
    Ann N Y Acad Sci; 1989; 567():14-25. PubMed ID: 2679314
    [No Abstract]   [Full Text] [Related]  

  • 13. Moloney murine leukemia virus-induced tumors: recombinant proviruses in active chromatin regions.
    van der Putten H; Quint W; Verma IM; Berns A
    Nucleic Acids Res; 1982 Jan; 10(2):577-92. PubMed ID: 6278422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T and B lymphocyte susceptibility to murine leukemia virus moloney.
    Isaak DD; Cerny J
    Infect Immun; 1983 Jun; 40(3):977-84. PubMed ID: 6602095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemogenicity of clonal isolates of murine leukemia viruses.
    Jolicoeur P; Rosenberg N; Cotellessa A; Baltimore D
    J Natl Cancer Inst; 1978 Jun; 60(6):1473-6. PubMed ID: 206713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses.
    Chatis PA; Holland CA; Hartley JW; Rowe WP; Hopkins N
    Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4408-11. PubMed ID: 6308622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moloney leukemia virus gene expression and gene amplification in preleukemic and leukemic BALB/Mo mice.
    Jaenisch R
    Virology; 1979 Feb; 93(1):80-90. PubMed ID: 571169
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell populations and known surface antigens of tumors induced by Abelson virus in pristane-primed BALB/c mice: an analysis by immunoelectron microscopy;
    Aoki T; Potter M; Sturm MM; Liu M; Walling MJ
    J Natl Cancer Inst; 1975 Nov; 55(5):1097-106. PubMed ID: 173861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ts1, a mutant of Moloney murine leukemia virus-TB, causes both immunodeficiency and neurologic disorders in BALB/c mice.
    Wong PK; Prasad G; Hansen J; Yuen PH
    Virology; 1989 Jun; 170(2):450-9. PubMed ID: 2728346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.